Cubist Systematic Strategies, LLC Verrica Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.88 - $8.51 $49,988 - $147,708	17,357 New	17,357 $112,000
Q3 2022 Nov 14, 2022	BUY	$2.17 - $4.3 $17,841 - $35,354	8,222 Added 685.17%	9,422 $28,000
Q2 2022 Aug 15, 2022	BUY	$1.81 - $8.93 $2,172 - $10,716	1,200 New	1,200 $2,000
Q1 2019 May 15, 2019	SELL	$7.95 - $14.07 $3,378 - $5,979	-425 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.75 - $16.12 $10,037 - $23,970	-1,487 Reduced 77.77%	425 $3,000
Q3 2018 Nov 14, 2018	BUY	$13.94 - $19.88 $26,653 - $38,010	1,912 New	1,912 $31,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.